1LyMwl4

92 REVISTA ARGENTINA DE CARDIOLOGÍA / VOL 83 SUPLEMENTO 2 / JUNIO 2015
60. O’Brien MF, Stafford EG, Gardner MA, Pohlner PG, Tesar PJ,
Cochrane AD, et al. Allograft aortic valve replacement: long-term
follow-up. Ann Thorac Surg 1995;60:S65-70.
61. Puvimanasinghe JP, Steyerberg EW, Takkenberg JJ, Eijkemans
MJ, van Herwerden LA, Bogers AJ, et al. Prognosis after aortic valve
replacement with a bioprosthesis: predictions based on meta-analysis
and microsimulation. Circulation 2001;103:1535-41.
62. Remadi JP, Baron O, Roussel C, Bizouarn P, Habasch A, Despins
P, et al. Isolated mitral valve replacement with St. Jude medical
prosthesis: long-term results: a follow-up of 19 years. Circulation
2001;103:1542-5.
63. O’Rourke DJ, Palac RT, Malenka DJ, Marrin CA, Arbuckle BE,
Plehn JF, et al. Outcome of mild periprosthetic regurgitation detected
by intraoperative transesophageal echocardiography. J Am Coll
Cardiol 2001;38:163-6.
64. Rallidis LS, Moyssakis IE, Ikonomidis I, Nihoyannopoulos P.
Natural history of early aortic paraprosthetic regurgitation: a fiveyear
follow-up. Am Heart J 1999;138:351-7.
65. Zamorano JL., Badano LP, Bruce C, Chan K-L., Gonalves A, Hahn
RT, et al. EAE/ASE recommendations for the use of echocardiography
in new transcatheter interventions for valvular heart disease. Eur
Heart J 2011;32:2189-214.
66. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves.
N Engl J Med 1996;335:407-16.
67. Cianciulli TF, Lax JA, Beck MA, Cerruti FE, Gigena GE, Saccheri
MC y cols. Características cinefluoroscópicas de ocho modelos de
prótesis mecánicas bivalvas implantadas en la República Argentina:
su valor complementario al ecocardiograma Doppler color. Rev Argent
Cardiol 2008;76:27-35.
68. Cianciulli TE, Lax JA, Beck MA, Cerruti FE, Gigena GE, Saccheri
MC, et al. Cinefluoroscopic assessment of mechanical disc prostheses:
its value as a complementary method to echocardiography. J Heart
Valve Dis 2005;14:664-73.
69. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian
C, Rahimtoola SH. Outcomes 15 years after valve replacement with a
mechanical versus a bioprosthetic valve: final report of the Veterans
Affairs randomized trial. J Am Coll Cardiol 2000;36:1152-8.
70. Glower DD, Landolfo KP, Cheruvu S, Cen YY, Harrison JK,
Bashore TM, et al. Determinants of 15-year outcome with 1,119
standard Carpentier-Edwards porcine valves. Ann Thorac Surg
1998;66:S44-8.
71. Poirer NC, Pelletier LC, Pellerin M, Carrier M. 15-year experience
with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac
Surg 1998;66:S57-61.
72. Brennan JM, Edwards FH, Zhao Y, O’Brien S, Booth ME, Dokholyan
RS, et al, on behalf of the DEcIDE AVR Research Team.
Long-term safety and effectiveness of mechanical versus biologic
aortic valve prostheses in older patients: results from the Society
of Thoracic Surgeons Adult Cardiac Surgery National Database.
Circulation 2013;127:1647-55.
73. Rahimtoola SH. Valve prosthesis-patient mismatch: an update.
J Heart Valve Dis 1998;7:207-10.
74. Pibarot P, Dumesnil JG. Hemodynamic and clinical impact of
prosthesis-patient mismatch in the aortic valve position and its
prevention. J Am Coll Cardiol 2000;36:1131-41.
75. David TE. Is prosthesis-patient mismatch a clinically relevant
entity? Circulation 2005;111:3186-7.
76. Tasca G, Brunelli F, Cirillo M, DallaTomba M, Mhagna Z, Troise G,
et al. Impact of valve prosthesis-patient mismatch on left ventricular
mass regression following aortic valve replacement. Ann Thorac Surg
2005;79:505-10.
77. Jamieson WR, Janusz MT, MacNab J, Henderson C. Hemodynamic
comparison of second- and third-generation stented bioprostheses in
aortic valve replacement. Ann Thorac Surg 2001;71:S282-4.
78. Milano AD, De Carlo M, Mecozzi G, D’Alfonso A, Scioti G, Nardi
C, et al. Clinical outcome in patients with 19-mm and 21-mm St. Jude
aortic prostheses: comparison at long-term follow-up. Ann Thorac
Surg 2002;73:37-43.
79. Blot WJ, Ibrahim MA, Ivey TD, Acheson DE, Brookmeyer R,
Weyman A, et al. Twenty-five-year experience with the Björk-Shiley
convexoconcave heart valve: a continuing clinical concern. Circulation
2005;111:2850-7.
80. Deviri E, Sareli P, Wisenbaugh T, Cronje SL. Obstruction of
mechanical heart valve prostheses: clinical aspects and surgical
management. J Am Coll Cardiol 1991;17:646-50.
81. Roudaut R, Lafitte S, Roudaut MF, Courtault C, Perron JM, Jaïs
C, et al. Fibrinolysis of mechanical prosthetic valve thrombosis: a
single-center study of 127 cases. J Am Coll Cardiol 2003;41:653-8.
82. Alpert JS. The thrombosed prosthetic valve: current recommendations
based on evidence from the literature. J Am Coll Cardiol
2003;41:659-60.
83. Lengyel M, Fuster V, Keltai M, Roudaut R, Schulte HD, Seward
JB, et al. Guidelines for management of left-sided prosthetic valve
thrombosis: a role for thrombolytic therapy. Consensus Conference
on Prosthetic Valve Thrombosis. J Am Coll Cardiol 1997;30:1521-6.
84. Gupta D, Kothari SS, Bahl VK, Goswami KC, Talwar KK, Manchanda
SC, et al. Thrombolytic therapy for prosthetic valve thrombosis:
short- and long-term results. Am Heart J 2000;140:906-16.
85. Ozkan M, Kaymaz C, Kirma C, Sönmez K, Ozdemir N, Balkanay
M, et al. Intravenous thrombolytic treatment of mechanical prosthetic
valve thrombosis: a study using serial transesophageal echocardiography.
J Am Coll Cardiol 2000;35:1881-9.
86. Tong AT, Roudaut R, Ozkan M, Sagie A, Shahid MS, Pontes Júnior
SC, et al. Transesophageal echocardiography improves risk assessment
of thrombolysis of prosthetic valve thrombosis: results of the
international PRO-TEE registry. J Am Coll Cardiol 2004;43:77-84.
87. Roudat R, Serri K, Lafitte S. Thrombosis of prosthetic heart valve,
diagnosis and therapeutic considerations. Heart 2007;93:137-42.
88. Barbetseas J, Nagueh SF, Pitsavos C, Toutouzas PK, Quiñones MA,
Zoghbi WA, et al. Differentiating thrombus from pannus formation
in obstructed mechanical prosthetic valves: an evaluation of clinical,
transthoracic and transesophageal echocardiographic parameters. J
Am Coll Cardiol 1998;32:1410-7.
89. Rahimtoola SH. The problem of valve prosthesis-patient mismatch.
Circulation 1978;58:20-4.
90. Blais C, Dumesnil JG, Baillot R, Simard S, Doyle D, Pibarot P.
Impact of valve prosthesis-patient mismatch on short-term mortality
after aortic valve replacement. Circulation 2003;108:983-8.
91. Pibarot P, Dumesnil JG. Valve prosthesis-patient mismatch, 1978
to 2011: from original concept to compelling evidence. J Am Coll
Cardiol 2012;60:1136-9.
92. Barbetseas J, Pitsavos C, Aggeli C, Psarros T, Frogoudaki A,
Lambrou S, et al. Comparison of frequency of left atrial thrombus in
patients with mechanical prosthetic cardiac valves and stroke versus
transient ischemic attacks. Am J Cardiol 1997;80:526-8.
93. Shiran A, Weissman NJ, Merdler A, Karkabi B, Khader N, Aviram
S, et al. Transesophageal echocardiographic findings in patients with
nonobstructed prosthetic valves and suspected cardiac source of
embolism. Am J Cardiol 2001;88:1441-4.
94. Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ,
Vandenbroucke JP, Briët E, et al. Optimal oral anticoagulant therapy
in patients with mechanical heart valves. N Engl J Med 1995;333:11-7.
95. Cannegieter SC, Rosendaal FR, Briët E. Thromboembolic and
bleeding complications in patients with mechanical heart valve
prostheses. Circulation 1994;89:635-41.
96. Kloster FE. Diagnosis and management of complications of prosthetic
heart valves. Am J Cardiol 1975;35:872-85.
97. Ismeno G, Renzulli A, Carozza A, De Feo M, Iannuzzi M, Sante P,
et al. Intravascular hemolysis after mitral and aortic valve replacement
with different types of mechanical prostheses. Int J Cardiol
1999;69:179-83.
98. Skoularigis J, Essop MR, Skudicky D, Middlemost SJ, Sareli P.
Frequency and severity of intravascular hemolysis after left-sided
cardiac valve replacement with Medtronic Hall and St. Jude Medical
prostheses, and influence of prosthetic type, position, size and number.
Am J Cardiol 1993;71:587-91.